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Objectives: Brucellosis is one of the most common zoonoses in the world, and
occurs mainly in farmers, slaughterhouse workers, and veterinarians via direct or
indirect contact with infected animals or their products. The clinical symptoms
of human brucellosis are nonspecific, such as fever, headache, chills, and
sweating. Diagnosis and treatment of brucellosis requires laboratory tests.
Although the serum tube agglutination test (SAT) is the standardized gold
method, it is laborious, time consuming, and requires a number of reagents. A
microagglutination test (MAT) variant of the SAT or enzyme-linked immunosor-
bent assay (ELISA) is recommended for serological diagnoses. For the simple and
rapid diagnosis of brucellosis, the MAT was standardized using samples for the
SAT to define positive and negative categories, and we then compared the
sensitivity and specificity of the MAT and ELISA.
Methods: Thirty SAT-positive sera and 60 SAT-negative sera were used in this
study. Antibody titers of 1:160 were considered positive readings in both the
SAT and MAT. Brucella abortus antigens and Brucella-positive control antiserum
were used in the SAT and MAT. ELISAs of IgM and IgG were performed according to
the manufacturers’ instructions.
Results: The titers of the MAT differed according to antigen concentration. The
optimal concentration of B abortus antigen was determined to compare the
sensitivity and specificity between the MAT and SAT. The sensitivity and speci-
ficity of the MAT were 93.3% and 96.7%, respectively, for IgG with reference to
ELISA, and 96.7% and 98.3%, respectively, for IgM.
Conclusions: The optimal concentration of antigen for the MAT was 1:10. The
MAT is less time consuming and requires less antigen and serum than the
SAT. The results of the MAT showed good agreement with those of ELISA.
The results of this study suggest that the MAT could be useful for diagnosis
of brucellosis.ibuted under the terms of the Creative Commons Attribution Non-Commercial License
y-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in
is properly cited.
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Brucellosis, caused by species of the Gram-negative
bacterium Brucella, continues to be a problem in
humans and animals throughout the world [1]. In Korea,
brucellosis is an endemic disease, and B abortus is the
prevailing strain in human infections [2]. Human
brucellosis occurs among livestock workers and veteri-
narians who live and work in rural areas with cattle
farms [3].
Clinically, Brucellosis is highly polymorphic and
induces inconstant fever, sweating, weakness, anemia,
headache, and depression [4]. Since the symptoms are
similar to those associated with other febrile diseases,
laboratory tests are required for the diagnosis and
treatment of brucellosis [5]. Although confirmation of
brucellosis requires isolation of the bacteria from blood,
several serological tests have been developed to facili-
tate the diagnosis of human brucellosis: the serum tube
agglutination test (SAT), anti-human globulin test,
indirect fluorescence antibody assay (IFA), and enzyme-
linked immunosorbent assay (ELISA) [6]. The most
frequently used method for diagnosing human brucel-
losis is serological screening with the SAT. Although
the SAT is a frequently performed method, it is labo-
rious, time consuming, and requires a number of
reagents, so it is unsuitable as a primary test in labora-
tories with a large specimen workload. The SAT is not
convenient for field use or for conducting serologic
surveys in the support of epidemiologic investigations.
Several rapid screening tests have been proposed, but
variations in antigens, incubation times, and interpreta-
tions of significant reactivity make it difficult to evaluate
their suitability for screening human sera. The micro-
agglutination test (MAT) has the advantage of being
able to process a large number of samples. ELISA may
differentiate between IgG and IgM antibodies. These
have shorter run times and require less training than
agglutination tests in interpreting results [2,7].
The purpose of this study was to standardize the MAT
for the simple and rapid diagnosis of brucellosis using
samples for the SAT to define positive and negative
categories. In addition, the utility of the SAT, MAT, and
ELISA as diagnostic tools for human brucellosis were
evaluated.2. Materials and Methods
2.1. Sera and antigen
Thirty serum samples from 30 patients with acute
brucellosis and 60 from healthy individuals were
included in this study. All serum samples were referred
between 2005 and 2009 for further laboratory diagnosis
under the suspicion of brucellosis. Appropriate Brucella
positive and negative sera (BD, Spark, Maryland, USA)
were used for all agglutination tests, as well as forcontrols. The diagnosis of brucellosis was based on
clinical findings along with identification of Brucella or
the presence of serum antibodies (SAT titer 1:160).
The antigen used was a commercial suspension of B
abortus (Germaine, San Antonio, Texas, USA and BD,
Spark, Maryland, USA), prepared according to the
manufacturers’ instructions. Titrations were made by
serial two-fold dilutions with 0.85% saline.
2.2. Serum tube agglutination test (SAT)
For the SAT, the procedural methods described
previously [8] were used. The working dilution of
antigen for the SAT was a 1:50 dilution of Brucella
suspension in 0.85% saline. Doubling dilutions of serum
were made with saline in tubes, from 1:10 to 1:1280
dilution. High, low, and negative reference sera of
known titers were used as controls. Each tube contained
0.5 ml of diluted serum, to which an equal amount of the
1:50 dilution (working dilution) of the antigens was
added. The contents of the tubes were mixed, and the
tubes incubated in a 37 C shaking incubator for 24 h.
2.3. Microagglutination test
The MAT was performed with a commercial
Brucella antigen as described previously [9], in 96-well
U-shaped microplates. Serial two-fold dilutions of the
sera were made in saline from 1:10 and to 1:1280. The
MAT was performed by incubating the sera at 37 C
for 24 h.
Each of the 90 sera were tested against Brucella using
tube agglutination as well as by microagglutination.
Appropriate positive and negative serum controls were
used for all tests as well as for controls. Before exam-
ination of the unknown sera by the agglutination test,
each antigen was tested to determine the optimal
concentration of the antigen dilution necessary for the
highest agglutination titer with specific antisera in the
MAT. To determine the optimal concentration, serial
two-fold dilutions of the antigens were tested against
similar dilutions of each control serum in a “block” or
“checkerboard” titration (Figure 1). Dilutions of sera
from 1:5 to 1:640 were made directly in microtiter
plates.
2.4. Enzyme linked immunosorbent
assay (ELISA)
ELISA of IgG and IgM were performed and inter-
preted using a commercial kit (Panbio, Brisbane,
Queensland, Australia) according to the manufacturer’s
instruction. Serum was diluted 1:100 in the diluents
provided with the ELISA kit before transfer to Brucella
antigen-coated microcells strips for 20 min at room
temperature (100 ml/well). Bound IgM was detected
after a washing with phosphate-buffered saline con-
taining 0.05% Tween 20, a 20-min incubation with anti-
human IgM peroxidase (100 ml/well), another washing,
and a 10-min incubation with tetramethylbenzidine
Figure 1. Comparison of titers of commercial Brucella abortus antigens. Block titration of B abortus antigen against the specific,
positive control antiserum for each antigen to determine the optimal concentration for use in the microtiter plate. (A) Titration of
commercial B abortus (Germaine) against positive control serum (BD). (B) Titration of commercial B abortus (BD) against
positive control serum (BD).
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addition of 100 ml of 1 M phosphoric acid per well, and
the strips were read at 450 nm. Each run included
positive, negative, and cutoff calibrator controls. An
index value (Panbio units) was calculated to generate the
results for either IgG or IgM as follows; negative, <9;
equivocal, 9 to 11; and positive, >11.
2.5. Statistical analysis
Contingency tables were formed with the antibody
titer data measured by the MAT and SAT. Case-by-case
associations between the MAT and SAT were estimated
by using the Spearman correlation. For this purpose,
agglutination units were changed to arbitrary units of
stepwise increments. Similarly, the other titers also
received higher values. A paired t test was used to obtain
the significance of the difference between the MAT and
SAT on the individual sample level. The difference in
the accumulated titer values obtained from all tested
serum samples was compared for the MAT and SAT by
general linear model analysis. Comparisons between the
SAT and the ELISA were made with the nonparametric
Mann-Whitney U test (SPSS v. 11.5, SPSS Inc, Chi-
cago, IL, USA).Figure 2. Correlation of agglutination titers as determined
by MAT and SAT. The line indicates the same titers in each
serologic test. The numbers indicate all samples tested with the
each diluted antigen. The symbols distinguish the antigen
dilution factor.3. Results
Standardization of antigen concentrations was
accomplished in the MAT using each antigen against its
specific control antiserum in a block titration (Figure 1).
When high concentrations of the antigens were used, the
antibody titers were low; conversely, low concentrations
of antigen resulted in high antibody titers. As determined
by the aforementioned procedure, the optimalconcentration of B abortus antigen was 1:20, because
all combinations of antigen and antiserum dilutions
showed complete dispersions of the antigens beyond
this point. When the commercial Brucella antigens
were diluted 1:10 with saline and compared with
OD600, their OD units were 0.76 and 0.79, respectively.
The concentrations of the antigens were similar. In the
MAT, there were no significant differences in antibody
titers against the commercial antigens (Figure 1). The
titer of the positive-control serum was 1:160 in the
SAT. Ninety sera each were tested by both the SAT and
MAT. There were significant differences between the
titers obtained using the SAT and MAT with both
negative and positive specimens. The SAT was
Table 1. Comparisons of sensitivity and specificity between MAT and ELISA
ELISA
IgG IgM IgGþ IgM
Positive Negative Positive Negative Positive Negative
MAT Positive (nZ 30) 28 2 29 1 30 0
MAT Negative (nZ 60) 2 58 1 59 2 58
Sensitivity 93.3% 96.7% 100%
Specificity 96.7% 98.3% 96.7%
22 S.-H. Park, et alnegative for the 60 healthy sera used as negative
controls. There were the same results between the SAT
and MAT with the 60 negative specimens. In contrast,
all patients presented SAT titers of 1:320. In the
MAT, each serum was titrated at 3 different antigen
dilutions (1:5, 1:10, and 1:20). The results were
compared at the individual sample level by testing
differences in titers obtained from each concentration
(Figure 2). When the antigens were diluted 1:10, the
titers were consistent with each other in 16 of the 30
patient sera, while the 13 other sera showed a one
phase-titer difference. When the antigens were diluted
1:5, the titers were consistent with each other in 5 sera.
When the antigens were diluted at 1:20, the titers were
consistent with each other in 9 sera. Thus, the optimal
concentration of B abortus antigen in the MAT was
1:10 dilution.
The results as tested by the SAT, MAT and ELISA is
shown in Table 1. When the IgG ELISA results were
compared to the MAT results, the sensitivity and spec-
ificity of the MAT were 93.3% and 96.7%, respectively.
There were 2 false positive and 2 false negative results
in the IgG ELISA. When the IgM ELISA results wereFigure 3. Distribution of ELISA in MAT titers. The concentrat
controls) and the subjects with 1:160 are presented as box plots
indicates the cutoff value for seroactivity to Brucella in ELISA.compared to the MAT results, the sensitivity and spec-
ificity were 96.7% and 98.3%, respectively. There was
one false positive and one false negative result in the
IgM ELISA.4. Discussion
The SAT as a diagnostic tool despite its recognized
limitations has led to controversy concerning its clinical
implications. The MAT was developed as a simpler and
more efficient test than the SAT [9]. However, there
have been few studies on the usefulness of the MAT for
the diagnosis of domestic human brucellosis. Further-
more, the appropriate concentration of commercial
antigens for the MAT has not yet been established.
In this study, we determined that the optimal
concentration of commercial antigens for the MAT is
1:10. The MAT was more specific and sensitive than
previously reported and was simpler to perform and the
results were easier to read than the SAT.
ELISAs of IgM and IgG were found to have good
agreement compared to the MAT. Disagreement betweenions of Brucella IgM (A) or IgG (B) in the <1:20 (negative
displaying medians and inter quartile ranges. The dotted line
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from both positive and negative patients (Figure 3). There
were two false negative results in the IgG ELISA, but
these were positive in the IgM ELISA. The reason for this
may be that the production of IgG antibody was delayed.
There was one false negative result in the IgM ELISA,
but it was found to be positive in the IgG ELISA. IgM
ELISA has a limited value in the diagnosis of acute
brucellosis. Sensitivity increased when the combined IgG
and IgM results were compared to agglutination results.
The ELISA assay may not have sufficient specificity to be
used as a diagnostic tool. The numbers of false positive
results in ELISAs of IgG and IgM were two and one,
respectively. The reasons for the false-positive results in
these specimens remains unclear, and similar results in
ELISAs of IgG and IgM have been reported [10,11].
For the diagnosis of brucellosis, the MAT offered
good results, which were in good agreement with those
of the ELISA. The results of this study suggest that the
MAT may be useful for the diagnosis of brucellosis.
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